Secure and highly productive vaccines can be obtained for two viral STIs: hepatitis B and HPV. These vaccines have represented main advances in STI avoidance. By the end of 2023, the HPV vaccine had been released as Section of program immunization programmes in 140countries, generally higher- and Center-revenue international locations. https://us.hc6.org/